RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
G&E Herbal Biotechnology Co Stock

G&E Herbal Biotechnology Co ROA 2024

G&E Herbal Biotechnology Co ROA

0.08

Ticker

4911.TWO

ISIN

TW0004911003

In 2024, G&E Herbal Biotechnology Co's return on assets (ROA) was 0.08, a 769.47% increase from the 0.01 ROA in the previous year.

G&E Herbal Biotechnology Co Aktienanalyse

What does G&E Herbal Biotechnology Co do?

G&E Herbal Biotechnology Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding G&E Herbal Biotechnology Co's Return on Assets (ROA)

G&E Herbal Biotechnology Co's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing G&E Herbal Biotechnology Co's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider G&E Herbal Biotechnology Co's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in G&E Herbal Biotechnology Co’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about G&E Herbal Biotechnology Co stock

What is the Return on Assets (ROA) of G&E Herbal Biotechnology Co this year?

The Return on Assets (ROA) of G&E Herbal Biotechnology Co is 0.08 undefined this year.

What was the ROA of G&E Herbal Biotechnology Co compared to the previous year?

The ROA of G&E Herbal Biotechnology Co has increased by 769.47% compared to the previous year.

What consequences do high ROA have for investors of G&E Herbal Biotechnology Co?

A high ROA is advantageous for investors of G&E Herbal Biotechnology Co, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in G&E Herbal Biotechnology Co?

A low ROA can be unfavorable for investors of G&E Herbal Biotechnology Co as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of G&E Herbal Biotechnology Co affect the company?

An increase in ROA of G&E Herbal Biotechnology Co can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of G&E Herbal Biotechnology Co impact the company?

A reduction in the ROA of G&E Herbal Biotechnology Co can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of G&E Herbal Biotechnology Co?

Some factors that can influence the ROA of G&E Herbal Biotechnology Co include revenue, operating costs, asset structure, and industry average.

Why is the ROA of G&E Herbal Biotechnology Co important for investors?

The ROA of G&E Herbal Biotechnology Co is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can G&E Herbal Biotechnology Co take to improve ROA?

To improve ROA, G&E Herbal Biotechnology Co can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does G&E Herbal Biotechnology Co pay?

Over the past 12 months, G&E Herbal Biotechnology Co paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, G&E Herbal Biotechnology Co is expected to pay a dividend of 0 TWD.

What is the dividend yield of G&E Herbal Biotechnology Co?

The current dividend yield of G&E Herbal Biotechnology Co is .

When does G&E Herbal Biotechnology Co pay dividends?

G&E Herbal Biotechnology Co pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of G&E Herbal Biotechnology Co?

G&E Herbal Biotechnology Co paid dividends every year for the past 0 years.

What is the dividend of G&E Herbal Biotechnology Co?

For the upcoming 12 months, dividends amounting to 0 TWD are expected. This corresponds to a dividend yield of 0 %.

In which sector is G&E Herbal Biotechnology Co located?

G&E Herbal Biotechnology Co is assigned to the 'Non-cyclical consumption' sector.

Wann musste ich die Aktien von G&E Herbal Biotechnology Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of G&E Herbal Biotechnology Co from 9/12/2024 amounting to 0.538 TWD, you needed to have the stock in your portfolio before the ex-date on 8/20/2024.

When did G&E Herbal Biotechnology Co pay the last dividend?

The last dividend was paid out on 9/12/2024.

What was the dividend of G&E Herbal Biotechnology Co in the year 2023?

In the year 2023, G&E Herbal Biotechnology Co distributed 0 TWD as dividends.

In which currency does G&E Herbal Biotechnology Co pay out the dividend?

The dividends of G&E Herbal Biotechnology Co are distributed in TWD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von G&E Herbal Biotechnology Co

Our stock analysis for G&E Herbal Biotechnology Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of G&E Herbal Biotechnology Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.